Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04307524Phase 3Unknown
Phase 3, randomised trial in cesarean scar defect (CSD) (2 arms), sponsored by Zagazig University. Primary endpoint: post-menstrual spotting at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04307524.